AtriCure Receives FDA 510(k) Clearance for Isolator(TM) Synergy(TM) Bipolar Ablation System and Performs First Case 
AtriCure, Inc. , a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today that it has received Food and Drug Administration 510 clearance for its Isolator Synergy Bipolar Ablation System for the ablation of soft tissue.